Preparing For Expansion: Perrigo Sets $500M Private Offering, Bausch + Lomb IPO Details Filed

Perrigo intends to use net proceeds from $500m private offering along with cash on hand and funds from previous credit facilities to finance acquisition of HRA Pharma. Bausch Health reduces debt by $200m as it prepares to target proceeds from planned Bausch + Lomb IPO also to paying down debt.